Long-term outcomes of cyclosporin treatment in ulcerative colitis
Author Information
Author(s): Actis Giovanni C, Fadda Maurizio, David Ezio, Sapino Anna
Primary Institution: Ospedale Molinette, Torino, Italy
Hypothesis
Can cyclosporin treatment reduce the need for colectomy in patients with steroid-refractory ulcerative colitis?
Conclusion
Sixty percent of patients with steroid-refractory colitis responded to cyclosporin, but the need for colectomy remains high over time.
Supporting Evidence
- 39 out of 61 patients initially responded to cyclosporin treatment.
- 61% of responders were colectomy-free after 1 year.
- The colectomy-free rate dropped to 35% after 7 years.
Takeaway
Doctors used a medicine called cyclosporin to help people with a bad tummy problem, and while it worked for some, many still needed surgery later.
Methodology
Retrospective cohort study of patients treated with cyclosporin for steroid-refractory ulcerative colitis from 1991 to 1999.
Potential Biases
Potential selection bias due to the retrospective nature of the study.
Limitations
The study is retrospective and may not account for all variables affecting outcomes.
Participant Demographics
Mean age 34 years, 36 males and 25 females.
Statistical Information
P-Value
0.0007
Statistical Significance
p=0.0007
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website